{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:46:41Z","timestamp":1792806401309,"version":"4.5.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s11940-012-0208-3","type":"journal-article","created":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T08:28:38Z","timestamp":1354264118000},"page":"13-27","source":"Crossref","is-referenced-by-count":90,"title":["Familial and Sporadic Hemiplegic Migraine: Diagnosis and Treatment"],"prefix":"10.1007","volume":"15","author":[{"given":"Nadine","family":"Pelzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anine H.","family":"Stam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel D.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela M.","family":"Terwindt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,1]]},"reference":[{"key":"208_CR1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1468-2982.2002.00371.x","volume":"22","author":"LL Thomsen","year":"2002","unstructured":"Thomsen LL, Kirchmann EM, Faerch RS, et al. An epidemiological survey of hemiplegic migraine. Cephalalgia. 2002;22:361\u201375.","journal-title":"Cephalalgia"},{"key":"208_CR2","unstructured":"The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24(Suppl 1):9\u2013160."},{"key":"208_CR3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJMra010917","volume":"346","author":"PJ Goadsby","year":"2002","unstructured":"Goadsby PJ, Lipton RB, Ferrari MD. Migraine \u2013 current understanding and treatment. N Engl J Med. 2002;346:257\u201370.","journal-title":"N Engl J Med"},{"issue":"Pt 1","key":"208_CR4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/brain\/117.1.199","volume":"117","author":"M Lauritzen","year":"1994","unstructured":"Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain. 1994;117(Pt 1):199\u2013210.","journal-title":"Brain"},{"key":"208_CR5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/ana.410090406","volume":"9","author":"J Olesen","year":"1981","unstructured":"Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol. 1981;9:344\u201352.","journal-title":"Ann Neurol"},{"key":"208_CR6","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1073\/pnas.071582498","volume":"98","author":"N Hadjikhani","year":"2001","unstructured":"Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA. 2001;98:4687\u201392.","journal-title":"Proc Natl Acad Sci USA"},{"key":"208_CR7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11916-003-0011-7","volume":"7","author":"ME Bigal","year":"2003","unstructured":"Bigal ME, Tepper SJ. Ergotamine and dihydroergotamine: a review. Curr Pain Headache Rep. 2003;7:55\u201362.","journal-title":"Curr Pain Headache Rep."},{"key":"208_CR8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0165-6147(93)90084-W","volume":"14","author":"MD Ferrari","year":"1993","unstructured":"Ferrari MD, Saxena PR. Clinical and experimental effects of sumatriptan in humans. Trends Pharmacol Sci. 1993;14:129\u201333.","journal-title":"Trends Pharmacol Sci"},{"key":"208_CR9","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1093\/brain\/awn094","volume":"131","author":"GG Schoonman","year":"2008","unstructured":"Schoonman GG, Van Der Grond J, Kortmann C, et al. Migraine headache is not associated with cerebral or meningeal vasodilatation\u2013a 3\u00a0T magnetic resonance angiography study. Brain. 2008;131:2192\u2013200.","journal-title":"Brain"},{"key":"208_CR10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.22292","volume":"69","author":"MS Asghar","year":"2011","unstructured":"Asghar MS, Hansen AE, Amin FM, et al. Evidence for a vascular factor in migraine. Ann Neurol. 2011;69:635\u201345.","journal-title":"Ann Neurol"},{"key":"208_CR11","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1468-2982.2009.01940.x","volume":"29","author":"AH Stam","year":"2009","unstructured":"Stam AH, Haan J, van den Maagdenberg AMJM, et al. Migraine and genetic and acquired vasculopathies. Cephalalgia. 2009;29:1006\u201317.","journal-title":"Cephalalgia"},{"key":"208_CR12","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N","volume":"47","author":"R Burstein","year":"2000","unstructured":"Burstein R, Yarnitsky D, Goor-Aryeh I, et al. An association between migraine and cutaneous allodynia. Ann Neurol. 2000;47:614\u201324.","journal-title":"Ann Neurol"},{"key":"208_CR13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1468-1331.2003.00621.x","volume":"10","author":"LL Thomsen","year":"2003","unstructured":"Thomsen LL, Olesen J, Russell MB. Increased risk of migraine with typical aura in probands with familial hemiplegic migraine and their relatives. Eur J Neurol. 2003;10:421\u20137.","journal-title":"Eur J Neurol"},{"key":"208_CR14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1526-4610.2006.00286.x","volume":"46","author":"MK Eriksen","year":"2006","unstructured":"Eriksen MK, Thomsen LL, Olesen J. Implications of clinical subtypes of migraine with aura. Headache. 2006;46:286\u201397.","journal-title":"Headache"},{"key":"208_CR15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1468-2982.1995.1506477.x","volume":"15","author":"J Haan","year":"1995","unstructured":"Haan J, Terwindt GM, Ophoff RA, et al. Is familial hemiplegic migraine a hereditary form of basilar migraine? Cephalalgia. 1995;15:477\u201381.","journal-title":"Cephalalgia"},{"key":"208_CR16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1474-4422(11)70048-5","volume":"10","author":"MB Russell","year":"2011","unstructured":"Russell MB, Ducros A. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol. 2011;10:457\u201370. An excellent and extensive review article about many aspects of HM.","journal-title":"Lancet Neurol"},{"key":"208_CR17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM200107053450103","volume":"345","author":"A Ducros","year":"2001","unstructured":"Ducros A, Denier C, Joutel A, et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med. 2001;345:17\u201324.","journal-title":"N Engl J Med"},{"key":"208_CR18","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.1031","volume":"49","author":"EE Kors","year":"2001","unstructured":"Kors EE, Terwindt GM, Vermeulen FL, et al. Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann Neurol. 2001;49:753\u201360.","journal-title":"Ann Neurol"},{"key":"208_CR19","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1212\/01.WNL.0000127310.11526.FD","volume":"62","author":"K Jurkat-Rott","year":"2004","unstructured":"Jurkat-Rott K, Freilinger T, Dreier JP, et al. Variability of familial hemiplegic migraine with novel ATP1A2 Na+\/K\u2009+\u2009-ATPase variants. Neurology. 2004;62:1857\u201361.","journal-title":"Neurology"},{"key":"208_CR20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0092-8674(00)81373-2","volume":"87","author":"RA Ophoff","year":"1996","unstructured":"Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996;87:543\u201352.","journal-title":"Cell"},{"key":"208_CR21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00439-009-0684-z","volume":"126","author":"B Vries de","year":"2009","unstructured":"de Vries B, Frants RR, Ferrari MD, van den Maagdenberg AMJM. Molecular genetics of migraine. Hum Genet. 2009;126:115\u201332.","journal-title":"Hum Genet"},{"key":"208_CR22","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1001\/archneur.60.5.684","volume":"60","author":"EE Kors","year":"2003","unstructured":"Kors EE, Haan J, Giffin NJ, et al. Expanding the phenotypic spectrum of the CACNA1A gene T666M mutation: a description of 5 families with familial hemiplegic migraine. Arch Neurol. 2003;60:684\u20138.","journal-title":"Arch Neurol"},{"key":"208_CR23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/humu.9361","volume":"26","author":"F Riant","year":"2005","unstructured":"Riant F, De Fusco M, Aridon P, et al. ATP1A2 mutations in 11 families with familial hemiplegic migraine. Hum Mutat. 2005;26:281.","journal-title":"Hum Mutat"},{"key":"208_CR24","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1468-2982.2008.01603.x","volume":"28","author":"A Lebas","year":"2008","unstructured":"Lebas A, Guyant-Marechal L, Hannequin D, et al. Severe attacks of familial hemiplegic migraine, childhood epilepsy and ATP1A2 mutation. Cephalalgia. 2008;28:774\u20137.","journal-title":"Cephalalgia"},{"key":"208_CR25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ana.20760","volume":"59","author":"KR Vanmolkot","year":"2006","unstructured":"Vanmolkot KR, Stroink H, Koenderink JB, et al. Severe episodic neurological deficits and permanent mental retardation in a child with a novel FHM2 ATP1A2 mutation. Ann Neurol. 2006;59:310\u20134.","journal-title":"Ann Neurol"},{"key":"208_CR26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10048-004-0183-2","volume":"5","author":"M Spadaro","year":"2004","unstructured":"Spadaro M, Ursu S, Lehmann-Horn F, et al. A G301R Na+\/K\u2009+\u2009-ATPase mutation causes familial hemiplegic migraine type 2 with cerebellar signs. Neurogenetics. 2004;5:177\u201385.","journal-title":"Neurogenetics"},{"key":"208_CR27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0140-6736(05)66786-4","volume":"366","author":"M Dichgans","year":"2005","unstructured":"Dichgans M, Freilinger T, Eckstein G, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet. 2005;366:371\u20137.","journal-title":"Lancet"},{"key":"208_CR28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1212\/WNL.0b013e3181f25e8f","volume":"75","author":"F Riant","year":"2010","unstructured":"Riant F, Ducros A, Ploton C, et al. De novo mutations in ATP1A2 and CACNA1A are frequent in early-onset sporadic hemiplegic migraine. Neurology. 2010;75:967\u201372.","journal-title":"Neurology"},{"key":"208_CR29","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1212\/01.wnl.0000295670.01629.5a","volume":"69","author":"B Vries de","year":"2007","unstructured":"de Vries B, Freilinger T, Vanmolkot KR, et al. Systematic analysis of three FHM genes in 39 sporadic patients with hemiplegic migraine. Neurology. 2007;69:2170\u20136.","journal-title":"Neurology"},{"key":"208_CR30","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/brain\/awl334","volume":"130","author":"LL Thomsen","year":"2007","unstructured":"Thomsen LL, Kirchmann M, Bjornsson A, et al. The genetic spectrum of a population-based sample of familial hemiplegic migraine. Brain. 2007;130:346\u201356.","journal-title":"Brain"},{"key":"208_CR31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1375\/twin.15.1.120","volume":"15","author":"S Stuart","year":"2012","unstructured":"Stuart S, Roy B, Davies G, et al. Detection of a novel mutation in the CACNA1A gene. Twin Res Hum Genet. 2012;15:120\u20135.","journal-title":"Twin Res Hum Genet."},{"key":"208_CR32","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1468-2982.2008.01599.x","volume":"28","author":"LL Thomsen","year":"2008","unstructured":"Thomsen LL, Oestergaard E, Bjornsson A, et al. Screen for CACNA1A and ATP1A2 mutations in sporadic hemiplegic migraine patients. Cephalalgia. 2008;28:914\u201321.","journal-title":"Cephalalgia"},{"key":"208_CR33","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archneur.59.6.1016","volume":"59","author":"G Terwindt","year":"2002","unstructured":"Terwindt G, Kors E, Haan J, et al. Mutation analysis of the CACNA1A calcium channel subunit gene in 27 patients with sporadic hemiplegic migraine. Arch Neurol. 2002;59:1016\u20138.","journal-title":"Arch Neurol"},{"key":"208_CR34","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1212\/WNL.55.7.1040","volume":"55","author":"K Vahedi","year":"2000","unstructured":"Vahedi K, Denier C, Ducros A, et al. CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy. Neurology. 2000;55:1040\u20132.","journal-title":"Neurology"},{"key":"208_CR35","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2169\/internalmedicine.37.166","volume":"37","author":"R Hayashi","year":"1998","unstructured":"Hayashi R, Tachikawa H, Watanabe R, et al. Familial hemiplegic migraine with irreversible brain damage. Intern Med. 1998;37:166\u20138.","journal-title":"Intern Med."},{"key":"208_CR36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00234-003-0979-z","volume":"45","author":"DJ Butteriss","year":"2003","unstructured":"Butteriss DJ, Ramesh V, Birchall D. Serial MRI in a case of familial hemiplegic migraine. Neuroradiology. 2003;45:300\u20133.","journal-title":"Neuroradiology"},{"key":"208_CR37","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1526-4610.2005.00249.x","volume":"45","author":"SD Spacey","year":"2005","unstructured":"Spacey SD, Vanmolkot KR, Murphy C, et al. Familial hemiplegic migraine presenting as recurrent encephalopathy in a Native Indian family. Headache. 2005;45:1244\u20139.","journal-title":"Headache"},{"key":"208_CR38","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.braindev.2011.11.002","volume":"34","author":"K Ohmura","year":"2012","unstructured":"Ohmura K, Suzuki Y, Saito Y, et al. Sporadic hemiplegic migraine presenting as acute encephalopathy. Brain Dev. 2012;34:691\u20135.","journal-title":"Brain Dev"},{"key":"208_CR39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10194-008-0067-1","volume":"9","author":"R Bhatia","year":"2008","unstructured":"Bhatia R, Desai S, Tripathi M, et al. Sporadic hemiplegic migraine: report of a case with clinical and radiological features. J Headache Pain. 2008;9:385\u20138.","journal-title":"J Headache Pain."},{"key":"208_CR40","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1468-2982.2006.01131.x","volume":"26","author":"A Jacob","year":"2006","unstructured":"Jacob A, Mahavish K, Bowden A, et al. Imaging abnormalities in sporadic hemiplegic migraine on conventional MRI, diffusion and perfusion MRI and MRS. Cephalalgia. 2006;26:1004\u20139.","journal-title":"Cephalalgia"},{"key":"208_CR41","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1212\/01.WNL.0000176298.63840.99","volume":"64","author":"JP Dreier","year":"2005","unstructured":"Dreier JP, Jurkat-Rott K, Petzold GC, et al. Opening of the blood-brain barrier preceding cortical edema in a severe attack of FHM type II. Neurology. 2005;64:2145\u20137.","journal-title":"Neurology"},{"key":"208_CR42","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1468-2982.2005.01025.x","volume":"26","author":"T Iizuka","year":"2006","unstructured":"Iizuka T, Sakai F, Suzuki K, et al. Implication of augmented vasogenic leakage in the mechanism of persistent aura in sporadic hemiplegic migraine. Cephalalgia. 2006;26:332\u20135.","journal-title":"Cephalalgia"},{"key":"208_CR43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10194-008-0074-2","volume":"9","author":"C Mjaset","year":"2008","unstructured":"Mjaset C, Russell MB. Intravenous nimodipine worsening prolonged attack of familial hemiplegic migraine. J Headache Pain. 2008;9:381\u20134.","journal-title":"J Headache Pain."},{"key":"208_CR44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000079546","volume":"52","author":"K Beauvais","year":"2004","unstructured":"Beauvais K, Cave-Riant F, De Barace C, et al. New CACNA1A gene mutation in a case of familial hemiplegic migraine with status epilepticus. Eur Neurol. 2004;52:58\u201361.","journal-title":"Eur Neurol"},{"key":"208_CR45","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/088307380201700617","volume":"17","author":"CI Prodan","year":"2002","unstructured":"Prodan CI, Holland NR, Lenaerts ME, Parke JT. Magnetic resonance angiogram evidence of vasospasm in familial hemiplegic migraine. J Child Neurol. 2002;17:470\u20132.","journal-title":"J Child Neurol."},{"key":"208_CR46","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1526-4610.2003.03014.x","volume":"43","author":"P Gonzalez-Alegre","year":"2003","unstructured":"Gonzalez-Alegre P, Tippin J. Prolonged cortical electrical depression and diffuse vasospasm without ischemia in a case of severe hemiplegic migraine during pregnancy. Headache. 2003;43:72\u20135.","journal-title":"Headache"},{"key":"208_CR47","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1468-2982.2006.01002.x","volume":"26","author":"F Pierelli","year":"2006","unstructured":"Pierelli F, Grieco GS, Pauri F, et al. A novel ATP1A2 mutation in a family with FHM type II. Cephalalgia. 2006;26:324\u20138.","journal-title":"Cephalalgia"},{"key":"208_CR48","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1526-4610.1995.hed3506368.x","volume":"35","author":"E Motta","year":"1995","unstructured":"Motta E, Rosciszewska D, Miller K. Hemiplegic migraine with CSF abnormalities. Headache. 1995;35:368\u201370.","journal-title":"Headache"},{"issue":"Pt 7","key":"208_CR49","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/brain\/120.7.1105","volume":"120","author":"F Gomez-Aranda","year":"1997","unstructured":"Gomez-Aranda F, Canadillas F, Marti-Masso JF, et al. Pseudomigraine with temporary neurological symptoms and lymphocytic pleocytosis. A report of 50 cases. Brain. 1997;120(Pt 7):1105\u201313.","journal-title":"Brain"},{"key":"208_CR50","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1212\/WNL.45.9.1648","volume":"45","author":"MJ Berg","year":"1995","unstructured":"Berg MJ, Williams LS. The transient syndrome of headache with neurologic deficits and CSF lymphocytosis. Neurology. 1995;45:1648\u201354.","journal-title":"Neurology"},{"key":"208_CR51","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1468-2982.2009.01950.x","volume":"30","author":"A Yilmaz","year":"2010","unstructured":"Yilmaz A, Kaleagasi H, Dogu O, et al. Abnormal MRI in a patient with \u2018headache with neurological deficits and CSF lymphocytosis (HaNDL). Cephalalgia. 2010;30:615\u20139.","journal-title":"Cephalalgia"},{"key":"208_CR52","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s13760-012-0018-0","volume":"112","author":"I Raets","year":"2012","unstructured":"Raets I. Diffusion restriction in the splenium of the corpus callosum in a patient with the syndrome of transient headache with neurological deficits and CSF lymphocytosis (HaNDL): a challenge to the diagnostic criteria? Acta Neurol Belg. 2012;112:67\u20139.","journal-title":"Acta Neurol Belg"},{"key":"208_CR53","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1046\/j.1526-4610.2003.03168.x","volume":"43","author":"KM Chapman","year":"2003","unstructured":"Chapman KM, Szczygielski BI, Toth C, et al. Pseudomigraine with lymphocytic pleocytosis: a calcium channelopathy? Clinical description of 10 cases and genetic analysis of the familial hemiplegic migraine gene CACNA1A. Headache. 2003;43:892\u20135.","journal-title":"Headache"},{"key":"208_CR54","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/ng.2358","volume":"44","author":"EL Heinzen","year":"2012","unstructured":"Heinzen EL, Swoboda KJ, Hitomi Y, et al. De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat Genet. 2012;44:1030\u20134.","journal-title":"Nat Genet"},{"key":"208_CR55","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/ana.410380517","volume":"38","author":"M Hutchinson","year":"1995","unstructured":"Hutchinson M, O\u2019Riordan J, Javed M, et al. Familial hemiplegic migraine and autosomal dominant arteriopathy with leukoencephalopathy (CADASIL). Ann Neurol. 1995;38:817\u201324.","journal-title":"Ann Neurol"},{"key":"208_CR56","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1212\/WNL.38.5.751","volume":"38","author":"P Montagna","year":"1988","unstructured":"Montagna P, Gallassi R, Medori R, et al. MELAS syndrome: characteristic migrainous and epileptic features and maternal transmission. Neurology. 1988;38:751\u20134.","journal-title":"Neurology"},{"key":"208_CR57","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1177\/0333102411415878","volume":"31","author":"JM Hansen","year":"2011","unstructured":"Hansen JM, Hauge AW, Ashina M, Olesen J. Trigger factors for familial hemiplegic migraine. Cephalalgia. 2011;31:1274\u201381.","journal-title":"Cephalalgia"},{"key":"208_CR58","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.psyneuen.2007.03.006","volume":"32","author":"GG Schoonman","year":"2007","unstructured":"Schoonman GG, Evers DJ, Ballieux BE, et al. Is stress a trigger factor for migraine? Psychoneuroendocrinology. 2007;32:532\u20138.","journal-title":"Psychoneuroendocrinology"},{"key":"208_CR59","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neulet.2010.10.064","volume":"487","author":"Q Ye","year":"2011","unstructured":"Ye Q, Yan LY, Xue LJ, et al. Flunarizine blocks voltage-gated Na(+) and Ca(2+) currents in cultured rat cortical neurons: a possible locus of action in the prevention of migraine. Neurosci Lett. 2011;487:394\u20139.","journal-title":"Neurosci Lett"},{"key":"208_CR60","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1526-4610.1987.hed2709487.x","volume":"27","author":"M Tobita","year":"1987","unstructured":"Tobita M, Hino M, Ichikawa N, et al. A case of hemiplegic migraine treated with flunarizine. Headache. 1987;27:487\u20138.","journal-title":"Headache"},{"key":"208_CR61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pediatrneurol.2012.04.012","volume":"47","author":"A Cunto De","year":"2012","unstructured":"De Cunto A, Bensa M, Tonelli A. A case of familial hemiplegic migraine associated with a novel ATP1A2 gene mutation. Pediatr Neurol. 2012;47:133\u20136.","journal-title":"Pediatr Neurol"},{"key":"208_CR62","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1469-8749.2011.04154.x","volume":"54","author":"BP Mohamed","year":"2012","unstructured":"Mohamed BP, Goadsby PJ, Prabhakar P. Safety and efficacy of flunarizine in childhood migraine: 11\u00a0years\u2019 experience, with emphasis on its effect in hemiplegic migraine. Dev Med Child Neurol. 2012;54:274\u20137.","journal-title":"Dev Med Child Neurol."},{"key":"208_CR63","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/sj.bjp.0702574","volume":"127","author":"D Dobrev","year":"1999","unstructured":"Dobrev D, Milde AS, Andreas K, Ravens U. The effects of verapamil and diltiazem on N-, P- and Q-type calcium channels mediating dopamine release in rat striatum. Br J Pharmacol. 1999;127:576\u201382.","journal-title":"Br J Pharmacol"},{"key":"208_CR64","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1212\/WNL.57.9.1732","volume":"57","author":"W Yu","year":"2001","unstructured":"Yu W, Horowitz SH. Familial hemiplegic migraine and its abortive therapy with intravenous verapamil. Neurology. 2001;57:1732\u20133.","journal-title":"Neurology"},{"key":"208_CR65","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1212\/01.WNL.0000042051.16284.70","volume":"60","author":"W Yu","year":"2003","unstructured":"Yu W, Horowitz SH. Treatment of sporadic hemiplegic migraine with calcium-channel blocker verapamil. Neurology. 2003;60:120\u20131.","journal-title":"Neurology"},{"key":"208_CR66","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/archneur.57.9.1363","volume":"57","author":"M Razavi","year":"2000","unstructured":"Razavi M, Razavi B, Fattal D, et al. Hemiplegic migraine induced by exertion. Arch Neurol. 2000;57:1363\u20135.","journal-title":"Arch Neurol"},{"key":"208_CR67","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1468-2982.1997.1702093.x","volume":"17","author":"FM Cutrer","year":"1997","unstructured":"Cutrer FM, Limmroth V, Moskowitz MA. Possible mechanisms of valproate in migraine prophylaxis. Cephalalgia. 1997;17:93\u2013100.","journal-title":"Cephalalgia"},{"key":"208_CR68","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1468-1331.2009.02748.x","volume":"16","author":"S Evers","year":"2009","unstructured":"Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine\u2013revised report of an EFNS task force. Eur J Neurol. 2009;16:968\u201381.","journal-title":"Eur J Neurol"},{"key":"208_CR69","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/WNL.48.1.261","volume":"48","author":"JF Rothrock","year":"1997","unstructured":"Rothrock JF. Successful treatment of persistent migraine aura with divalproex sodium. Neurology. 1997;48:261\u20132.","journal-title":"Neurology"},{"key":"208_CR70","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0014-2999(96)00265-8","volume":"307","author":"A Stefani","year":"1996","unstructured":"Stefani A, Spadoni F, Siniscalchi A, Bernardi G. Lamotrigine inhibits Ca2+ currents in cortical neurons: functional implications. Eur J Pharmacol. 1996;307:113\u20136.","journal-title":"Eur J Pharmacol"},{"key":"208_CR71","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1468-2982.1997.1702109.x","volume":"17","author":"TJ Steiner","year":"1997","unstructured":"Steiner TJ, Findley LJ, Yuen AW. Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia. 1997;17:109\u201312.","journal-title":"Cephalalgia"},{"key":"208_CR72","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1046\/j.1526-4610.2001.01150.x","volume":"41","author":"WT Chen","year":"2001","unstructured":"Chen WT, Fuh JL, Lu SR, Wang SJ. Persistent migrainous visual phenomena might be responsive to lamotrigine. Headache. 2001;41:823\u20135.","journal-title":"Headache"},{"key":"208_CR73","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1468-2982.1999.1901058.x","volume":"19","author":"C Lampl","year":"1999","unstructured":"Lampl C, Buzath A, Klinger D, Neumann K. Lamotrigine in the prophylactic treatment of migraine aura\u2013a pilot study. Cephalalgia. 1999;19:58\u201363.","journal-title":"Cephalalgia"},{"key":"208_CR74","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1468-2982.1999.1901064.x","volume":"19","author":"G D\u2019Andrea","year":"1999","unstructured":"D\u2019Andrea G, Granella F, Cadaldini M, Manzoni GC. Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study. Cephalalgia. 1999;19:64\u20136.","journal-title":"Cephalalgia"},{"key":"208_CR75","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/jnnp.2005.063750","volume":"76","author":"C Lampl","year":"2005","unstructured":"Lampl C, Katsarava Z, Diener HC, Limmroth V. Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry. 2005;76:1730\u20132.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"208_CR76","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1526-4610.2004.04198.x","volume":"44","author":"J Pascual","year":"2004","unstructured":"Pascual J, Caminero AB, Mateos V, et al. Preventing disturbing migraine aura with lamotrigine: an open study. Headache. 2004;44:1024\u20138.","journal-title":"Headache"},{"key":"208_CR77","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.nurt.2007.01.014","volume":"4","author":"M Strupp","year":"2007","unstructured":"Strupp M, Zwergal A, Brandt T. Episodic ataxia type 2. Neurotherapeutics. 2007;4:267\u201373.","journal-title":"Neurotherapeutics"},{"key":"208_CR78","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1212\/WNL.53.1.38","volume":"53","author":"S Battistini","year":"1999","unstructured":"Battistini S, Stenirri S, Piatti M, et al. A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. Neurology. 1999;53:38\u201343.","journal-title":"Neurology"},{"key":"208_CR79","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/ana.410400526","volume":"40","author":"BS Athwal","year":"1996","unstructured":"Athwal BS, Lennox GG. Acetazolamide responsiveness in familial hemiplegic migraine. Ann Neurol. 1996;40:820\u20131.","journal-title":"Ann Neurol"},{"key":"208_CR80","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1055\/s-0029-1223464","volume":"37","author":"HJ Koch","year":"2010","unstructured":"Koch HJ, Sykora A, Hausn P. Off-label use of acetazolamide in a patient with familial hemiplegic migraine and concomitant psychotic episodes. Psychiatr Prax. 2010;37:148\u201351.","journal-title":"Psychiatr Prax"},{"key":"208_CR81","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1526-4610.2005.05077_3.x","volume":"45","author":"R Simone De","year":"2005","unstructured":"De Simone R, Marano E, Di Stasio E, et al. Acetazolamide efficacy and tolerability in migraine with aura: a pilot study. Headache. 2005;45:385\u20136.","journal-title":"Headache"},{"key":"208_CR82","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/PL00007866","volume":"249","author":"K Vahedi","year":"2002","unstructured":"Vahedi K, Taupin P, Djomby R, et al. Efficacy and tolerability of acetazolamide in migraine prophylaxis: a randomized placebo-controlled trial. J Neurol. 2002;249:206\u201311.","journal-title":"J Neurol"},{"key":"208_CR83","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1468-2982.2002.00386.x","volume":"22","author":"SD Silberstein","year":"2002","unstructured":"Silberstein SD, Goadsby PJ. Migraine: preventive treatment. Cephalalgia. 2002;22:491\u2013512.","journal-title":"Cephalalgia"},{"key":"208_CR84","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jns.2008.05.015","volume":"272","author":"P Striano","year":"2008","unstructured":"Striano P, Zara F, Santorelli FM, Striano S. Topiramate-associated worsening symptoms in a patient with familial hemiplegic migraine. J Neurol Sci. 2008;272:194\u20135.","journal-title":"J Neurol Sci"},{"key":"208_CR85","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1526-4610.1987.hed2707381.x","volume":"27","author":"A Bardwell","year":"1987","unstructured":"Bardwell A, Trott JA. Stroke in migraine as a consequence of propranolol. Headache. 1987;27:381\u20133.","journal-title":"Headache"},{"key":"208_CR86","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/01.STR.9.4.344","volume":"9","author":"J Olesen","year":"1978","unstructured":"Olesen J, Hougard K, Hertz M. Isoproterenol and propranolol: ability to cross the blood-brain barrier and effects on cerebral circulation in man. Stroke. 1978;9:344\u20139.","journal-title":"Stroke"},{"key":"208_CR87","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ana.410080319","volume":"8","author":"B Zifkin","year":"1980","unstructured":"Zifkin B, Andermann E, Andermann F, Kirkham T. An autosomal dominant syndrome of hemiplegic migraine, nystagmus, and tremor. Ann Neurol. 1980;8:329\u201332.","journal-title":"Ann Neurol"},{"key":"208_CR88","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0022-3476(82)80293-X","volume":"101","author":"CW Lai","year":"1982","unstructured":"Lai CW, Ziegler DK, Lansky LL, Torres F. Hemiplegic migraine in childhood: diagnostic and therapeutic aspects. J Pediatr. 1982;101:696\u20139.","journal-title":"J Pediatr"},{"key":"208_CR89","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.braindev.2007.05.013","volume":"30","author":"DA Hsu","year":"2008","unstructured":"Hsu DA, Stafstrom CE, Rowley HA, et al. Hemiplegic migraine: hyperperfusion and abortive therapy with intravenous verapamil. Brain Dev. 2008;30:86\u201390.","journal-title":"Brain Dev"},{"key":"208_CR90","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.braindev.2010.05.006","volume":"33","author":"T Omata","year":"2011","unstructured":"Omata T, Takanashi J, Wada T, et al. Genetic diagnosis and acetazolamide treatment of familial hemiplegic migraine. Brain Dev. 2011;33:332\u20134.","journal-title":"Brain Dev"},{"issue":"Pt 1","key":"208_CR91","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/brain\/123.1.9","volume":"123","author":"P Tfelt-Hansen","year":"2000","unstructured":"Tfelt-Hansen P, Saxena PR, Dahlof C, et al. Ergotamine in the acute treatment of migraine: a review and European consensus. Brain. 2000;123(Pt 1):9\u201318.","journal-title":"Brain"},{"key":"208_CR92","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/01.CIR.98.1.25","volume":"98","author":"A Maassen van den Brink","year":"1998","unstructured":"Maassen van den Brink A, Reekers M, Bax WA, et al. Coronary side-effect potential of current and prospective antimigraine drugs. Circulation. 1998;98:25\u201330.","journal-title":"Circulation"},{"key":"208_CR93","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1046\/j.1526-4610.2001.01192.x","volume":"41","author":"J Klapper","year":"2001","unstructured":"Klapper J, Mathew N, Nett R. Triptans in the treatment of basilar migraine and migraine with prolonged aura. Headache. 2001;41:981\u201384.","journal-title":"Headache"},{"key":"208_CR94","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1468-1331.2007.01900.x","volume":"14","author":"V Artto","year":"2007","unstructured":"Artto V, Nissila M, Wessman M, et al. Treatment of hemiplegic migraine with triptans. Eur J Neurol. 2007;14:1053\u20136.","journal-title":"Eur J Neurol"},{"key":"208_CR95","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/bja\/77.4.441","volume":"77","author":"K Hirota","year":"1996","unstructured":"Hirota K, Lambert DG. Ketamine: its mechanism(s) of action and unusual clinical uses. Br J Anaesth. 1996;77:441\u20134.","journal-title":"Br J Anaesth"},{"key":"208_CR96","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1212\/WNL.55.1.139","volume":"55","author":"H Kaube","year":"2000","unstructured":"Kaube H, Herzog J, Kaufer T, et al. Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology. 2000;55:139\u201341.","journal-title":"Neurology"},{"key":"208_CR97","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1212\/WNL.0b013e3181b87942","volume":"73","author":"KM Connor","year":"2009","unstructured":"Connor KM, Shapiro RE, Diener HC, et al. Randomized, controlled trial of telcagepant for the acute treatment of migraine. Neurology. 2009;73:970\u20137.","journal-title":"Neurology"},{"key":"208_CR98","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(08)61626-8","volume":"372","author":"TW Ho","year":"2008","unstructured":"Ho TW, Ferrari MD, Dodick DW, et al. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomized, placebo-controlled, parallel-treatment trial. Lancet. 2008;372:2115\u201323.","journal-title":"Lancet"},{"key":"208_CR99","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11940-011-0155-4","volume":"14","author":"J Hoffmann","year":"2012","unstructured":"Hoffmann J, Goadsby PJ. New agents for acute treatment of migraine: CGRP Receptor Antagonists, iNOS Inhibitors. Curr Treat Options Neurol. 2012;14:50\u20139. A clear and recent review article about future pharmacological treatment options in migraine.","journal-title":"Curr Treat Options Neurol."},{"key":"208_CR100","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1526-4610.2011.01966.x","volume":"51","author":"B Jenkins","year":"2011","unstructured":"Jenkins B, Tepper SJ. Neurostimulation for primary headache disorders, part 1: pathophysiology and anatomy, history of neuromodulation in headache treatment, and review of peripheral neuromodulation in primary headaches. Headache. 2011;51:1254\u201366.","journal-title":"Headache"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-012-0208-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-012-0208-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-012-0208-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:58Z","timestamp":1559437018000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-012-0208-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,1]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["208"],"URL":"https:\/\/doi.org\/10.1007\/s11940-012-0208-3","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,1]]}}}